Joint Session of the ESR and ESC

ESR/ESC - CT/MRI in assessing valvular heart disease

Lectures

1
Chairpersons' introduction

Chairpersons' introduction

02:00Rodrigo Salgado, Antwerp / BE, Steffen Erhard Petersen, London / UK

2
Gaps in current guidelines for multimodality imaging of valvular heart disease

Gaps in current guidelines for multimodality imaging of valvular heart disease

20:00Victoria Delgado, Badalona / ES

3
The expanding toolbox of cardiac magnetic resonance imaging (CMR) for valvular heart disease

The expanding toolbox of cardiac magnetic resonance imaging (CMR) for valvular heart disease

20:00Jean-Nicolas Dacher, Rouen / FR

4
CT and valvular heart disease: a changing paradigm

CT and valvular heart disease: a changing paradigm

20:00Ricardo P. J. Budde, Rotterdam / NL

5
Redefining risk stratification in valvular heart disease by implementing AI-based imaging

Redefining risk stratification in valvular heart disease by implementing AI-based imaging

20:00Christoph Gräni, Bern / CH

6
Panel discussion: What are current and future challenges in valvular disease and imaging?

Panel discussion: What are current and future challenges in valvular disease and imaging?

08:00Panel discussion: What are current and future challenges in valvular disease and imaging?

2 min
Chairpersons' introduction
Steffen Erhard Petersen, London / United Kingdom
Rodrigo Salgado, Antwerp / Belgium
20 min
Gaps in current guidelines for multimodality imaging of valvular heart disease
Victoria Delgado, Badalona / Spain
  1. To learn the new multimodality cardiovascular imaging approach to diagnose and risk-stratify patients with valvular heart disease.
  2. To appreciate the right use of the right imaging modality at the right time, and therefore, to discuss the new recommendations.
  3. To understand the clinical implications of the imaging findings.
20 min
The expanding toolbox of cardiac magnetic resonance imaging (CMR) for valvular heart disease
Jean-Nicolas Dacher, Rouen / France
  1. To understand the complementary roles of echocardiography and CMR in the investigation of patients with valvular heart disease.
  2. To learn about the advantages and pitfalls of 2D and 4D phase contrast imaging in the analysis of valvular heart disease.
  3. To understand the importance of myocardial tissue characterisation in patients with valvular heart disease.
20 min
CT and valvular heart disease: a changing paradigm
Ricardo P. J. Budde, Rotterdam / Netherlands
  1. To learn what role CT can play in the assessment of valvular heart disease.
  2. To appreciate the various presentations of valvular pathology on CT.
  3. To understand the diagnostic information regarding valve disease that can be obtained with CT.
20 min
Redefining risk stratification in valvular heart disease by implementing AI-based imaging
Christoph Gräni, Bern / Switzerland
  1. To learn how AI-based imaging can enhance the assessment of valvular heart disease.
  2. To appreciate how novel AI-based biomarkers can improve risk stratification in valvular heart disease.
  3. To understand the potential benefits and limitations of integrating AI-based imaging into decision-making for patients with valvular heart disease.
8 min
Panel discussion: What are current and future challenges in valvular disease and imaging?

PEP Subscription Required

This course is only accessible for ESR Premium Education Package subscribers.